Institutional Ownership Uro Gen Pharma Ltd. (URGN)
This table provides information about the institutional ownership of Uro Gen Pharma Ltd. (URGN). We have compiled data on the 161 institutions that hold shares in the stock, with a total of 39.6 Million shares, which have been reported (via 13F filing form) to have a value of $781 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
104,226
shares
|
$2.06 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 27, 2025 Q2 2025 |
94,309
shares
|
$1.86 Million
0.0% of portfolio
|
Q2 2025
Added 187.84%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
93,396
shares
|
$1.84 Million
0.0% of portfolio
|
Q2 2025
Added 2869.67%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
92,957
shares
|
$1.84 Million
0.0% of portfolio
|
Q4 2024
Reduced 37.77%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
92,898
shares
|
$1.83 Million
0.0% of portfolio
|
Q2 2025
Reduced 0.69%
|
|
|
Superstring Capital Management LP
New York, NY |
Aug 14, 2025 Q2 2025 |
87,912
shares
|
$1.74 Million
1.43% of portfolio
|
Q2 2025
Reduced 79.25%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
83,146
shares
|
$1.64 Million
0.0% of portfolio
|
Q2 2025
Reduced 10.55%
|
|
|
Annandale Capital, LLC
Dallas, TX |
Aug 13, 2025 Q2 2025 |
75,552
shares
|
$1.49 Million
0.08% of portfolio
|
Q2 2024
Reduced 7.36%
|
|
|
Oak Ridge Investments LLC
|
Jul 25, 2025 Q2 2025 |
70,570
shares
|
$1.39 Million
0.07% of portfolio
|
Q2 2025
Reduced 4.25%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
70,154
shares
|
$1.39 Million
0.0% of portfolio
|
Q2 2025
Added 57.51%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Aug 14, 2025 Q2 2025 |
60,314
shares
|
$1.19 Million
0.0% of portfolio
|
Q2 2025
Added 497.64%
|
|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
53,400
shares
|
$1.05 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
51,293
shares
|
$1.01 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.06%
|
|
|
Hennion & Walsh Asset Management, Inc.
|
Aug 07, 2025 Q2 2025 |
38,355
shares
|
$757,511
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
38,200
shares
|
$754,450
0.0% of portfolio
|
Q2 2025
Reduced 57.84%
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
37,476
shares
|
$740,151
0.0% of portfolio
|
Q2 2025
Reduced 1.85%
|
|
|
Coastal Bridge Advisors, LLC
|
Aug 14, 2025 Q2 2025 |
37,000
shares
|
$730,750
0.05% of portfolio
|
Q1 2025
Reduced 5.13%
|
|
|
Meitav Dash Investments LTD
|
Jul 23, 2025 Q2 2025 |
36,138
shares
|
$713,725
0.01% of portfolio
|
Q3 2024
Reduced 1.79%
|
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
35,040
shares
|
$692,040
0.0% of portfolio
|
Q2 2025
Reduced 50.24%
|
|
|
Kovitz Investment Group Partners, LLC
|
Aug 14, 2025 Q2 2025 |
34,802
shares
|
$687,339
0.0% of portfolio
|
Q4 2024
Reduced 10.09%
|
|
|
Bender Robert & Associates
|
Jul 24, 2025 Q2 2025 |
34,701
shares
|
$685,344
0.11% of portfolio
|
Q2 2025
New holding
|
|
|
Persistent Asset Partners LTD
Hong Kong, K3 |
Aug 11, 2025 Q2 2025 |
34,600
shares
|
$683,350
0.35% of portfolio
|
Q2 2025
Added 96.92%
|
|
|
Virtu Financial LLC
New York, NY |
Aug 12, 2025 Q2 2025 |
34,004
shares
|
$671,579
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Los Angeles Capital Management LLC
|
Aug 06, 2025 Q2 2025 |
32,453
shares
|
$640,946
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
30,880
shares
|
$609,880
0.0% of portfolio
|
Q2 2025
Reduced 8.53%
|